Related Experiment Video
Updated: May 25, 2026
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.
E Patterson1, R Webb, A Weisbrod
1Endocrine Oncology Section, NIH/NCI/Surgery Branch, National Cancer Institute, NIH, Hatfield Clinical Research Center, Bethesda, Maryland 20892, USA.
Endocrine-Related Cancer
|January 14, 2012
Summary
New diagnostic markers for malignant pheochromocytoma are needed. This study identified specific microRNAs (miRNAs) in tumors and serum that show higher expression in malignant pheochromocytomas, suggesting their potential as diagnostic tools.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Malignant pheochromocytoma diagnosis currently relies on metastasis or local invasion.
- There is a critical need for novel biomarkers to identify tumors with malignant potential.
Purpose of the Study:
- To identify microRNAs (miRNAs) differentially expressed between benign and malignant pheochromocytomas.
- To evaluate the diagnostic accuracy of identified miRNAs for distinguishing malignant from benign tumors.
Main Methods:
- Whole genome microarray profiling was used to analyze miRNA expression in pheochromocytoma samples.
- Reverse transcription quantitative polymerase chain reaction (RT-PCR) was employed to validate miRNA expression levels.
- Receiver operating characteristic (ROC) curve analysis was performed to assess diagnostic accuracy.
Main Results:
- Eight miRNAs were found to be significantly differentially expressed between benign and malignant pheochromocytomas.
- miR-483-5p, miR-183, and miR-101 showed significantly higher expression in malignant tumors.
- These miRNAs were also detectable in patient serum samples.
Conclusions:
- The identified miRNAs (miR-483-5p, miR-101, and miR-183) show potential as diagnostic markers for malignant pheochromocytoma.
- Misexpression of these specific miRNAs is associated with the malignancy of pheochromocytoma.
- Serum detection of these miRNAs offers a promising avenue for non-invasive diagnosis.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...